Consequently, low prothrombin levels may weaken protective tumor microenvironment features such as fibrin-based shielding, thrombin-triggered survival signaling (via PAR-1 and related pathways), and immunosuppressive cell recruitment. This evidence concerns the gene F2 and neoplasm.